17-800961-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_022463.5(NXN):c.1296G>A(p.Pro432Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0209 in 1,481,678 control chromosomes in the GnomAD database, including 390 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.016 ( 31 hom., cov: 31)
Exomes 𝑓: 0.021 ( 359 hom. )
Consequence
NXN
NM_022463.5 synonymous
NM_022463.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.00
Genes affected
NXN (HGNC:18008): (nucleoredoxin) This gene encodes a member of the thioredoxin superfamily, a group of small, multifunctional redox-active proteins. Members of this family are characterized by a conserved active motif called the thioredoxin fold that catalyzes disulfide bond formation and isomerization. The encoded protein acts a redox-dependent regulator of the Wnt signaling pathway and is involved in cell growth and differentiation. [provided by RefSeq, Sep 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 17-800961-C-T is Benign according to our data. Variant chr17-800961-C-T is described in ClinVar as [Benign]. Clinvar id is 1632688.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0163 (2477/152112) while in subpopulation NFE AF= 0.0264 (1794/67972). AF 95% confidence interval is 0.0254. There are 31 homozygotes in gnomad4. There are 1103 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 31 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NXN | NM_022463.5 | c.1296G>A | p.Pro432Pro | synonymous_variant | 8/8 | ENST00000336868.8 | NP_071908.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NXN | ENST00000336868.8 | c.1296G>A | p.Pro432Pro | synonymous_variant | 8/8 | 1 | NM_022463.5 | ENSP00000337443.3 |
Frequencies
GnomAD3 genomes AF: 0.0163 AC: 2479AN: 151994Hom.: 31 Cov.: 31
GnomAD3 genomes
AF:
AC:
2479
AN:
151994
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0161 AC: 2838AN: 176288Hom.: 45 AF XY: 0.0160 AC XY: 1538AN XY: 96186
GnomAD3 exomes
AF:
AC:
2838
AN:
176288
Hom.:
AF XY:
AC XY:
1538
AN XY:
96186
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0215 AC: 28532AN: 1329566Hom.: 359 Cov.: 31 AF XY: 0.0213 AC XY: 13909AN XY: 653866
GnomAD4 exome
AF:
AC:
28532
AN:
1329566
Hom.:
Cov.:
31
AF XY:
AC XY:
13909
AN XY:
653866
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0163 AC: 2477AN: 152112Hom.: 31 Cov.: 31 AF XY: 0.0148 AC XY: 1103AN XY: 74358
GnomAD4 genome
AF:
AC:
2477
AN:
152112
Hom.:
Cov.:
31
AF XY:
AC XY:
1103
AN XY:
74358
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
8
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at